SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Affiliations

¹ AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France; INSERM UMRS-1166, Institute of Cardiometabolism and Nutrition, Paris, France. Electronic address: sacha.rozencwajg@aphp.fr.
² Lariboisière-Saint-Louis Hospitals, Department of Anaesthesiology, Critical Care and Burn Centre, DMU Parabol, AP-HP Nord, University of Paris, Paris, France; University of Paris, Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, France; University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
³ Univ. Lille, CHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de santé et des Pratiques médicales, F-59000, Lille, France.
⁴ Department of Anaesthesiology, Critical Care and Perioperative Medicine, Rouen University Hospital, 1 rue de Germont, 76000 Rouen, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
⁵ University of Amiens-Picardie, Departement of Anaesthesia and Critical Care, Amiens, France.
⁶ AP-HP, Beaujon University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Clichy, France; Inserm U1141 NeuroDiderot, Robert Debré Hospital, Paris, France.
⁷ University Hospital of Toulouse, Anaesthesia, Critical Care & Perioperative Medicine, Toulouse, France; University of Toulouse III, INSERM U1297, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France.
⁸ Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France.
⁹ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM UMR-1246, France.
¹⁰ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM U1070, Pharmacology of Antimicrobial Agents, University of Poitiers, France.
¹¹ Centre Hospitalier Universitaire La Cavale Blanche Université de Bretagne Ouest, Departement of Anaesthesiology, Critical Care and Perioperative Medicine, Brest, France.
¹² Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
¹³ Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesthésie Réanimation, 14000 Caen, France.

PMID: 33946037
PMCID: PMC8088124
DOI: 10.1016/j.accpm.2021.100874

Editorial

SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Sacha Rozencwajg et al. Anaesth Crit Care Pain Med. 2021 Jun.

. 2021 Jun;40(3):100874.

doi: 10.1016/j.accpm.2021.100874. Epub 2021 May 1.

Authors

Affiliations

¹ AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France; INSERM UMRS-1166, Institute of Cardiometabolism and Nutrition, Paris, France. Electronic address: sacha.rozencwajg@aphp.fr.
² Lariboisière-Saint-Louis Hospitals, Department of Anaesthesiology, Critical Care and Burn Centre, DMU Parabol, AP-HP Nord, University of Paris, Paris, France; University of Paris, Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, France; University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
³ Univ. Lille, CHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de santé et des Pratiques médicales, F-59000, Lille, France.
⁴ Department of Anaesthesiology, Critical Care and Perioperative Medicine, Rouen University Hospital, 1 rue de Germont, 76000 Rouen, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
⁵ University of Amiens-Picardie, Departement of Anaesthesia and Critical Care, Amiens, France.
⁶ AP-HP, Beaujon University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Clichy, France; Inserm U1141 NeuroDiderot, Robert Debré Hospital, Paris, France.
⁷ University Hospital of Toulouse, Anaesthesia, Critical Care & Perioperative Medicine, Toulouse, France; University of Toulouse III, INSERM U1297, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France.
⁸ Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France.
⁹ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM UMR-1246, France.
¹⁰ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM U1070, Pharmacology of Antimicrobial Agents, University of Poitiers, France.
¹¹ Centre Hospitalier Universitaire La Cavale Blanche Université de Bretagne Ouest, Departement of Anaesthesiology, Critical Care and Perioperative Medicine, Brest, France.
¹² Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
¹³ Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesthésie Réanimation, 14000 Caen, France.

PMID: 33946037
PMCID: PMC8088124
DOI: 10.1016/j.accpm.2021.100874

Abstract

We report data regarding three countries with similar healthcare systems which had three different vaccinal strategies between 1st of January and 10th of April 2021: rapid full vaccination (Israel), rapid first-dose vaccination (United Kingdom) and a delayed vaccination strategy (France).

PubMed Disclaimer

References

1. Peiffer-Smadja N, Rozencwajg S, Kherabi Y, et al. COVID-19 vaccines: A race against time. Anaesth Crit Care Pain Med 40:100848. 10.1016/j.accpm.2021.100848. - DOI - PMC - PubMed
1. Muik A, Wallisch A-K, Sänger B, et al. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science 371:1152-1153. 10.1126/science.abg6105. - DOI - PMC - PubMed
1. Fergie J, Srivastava A. Immunity to SARS-CoV-2: Lessons Learned. Front Immunol 12:654165. 10.3389/fimmu.2021.654165. - DOI - PMC - PubMed
1. Hoffmann M, Arora P, Groß R, et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 10.1016/j.cell.2021.03.036. - DOI - PMC - PubMed
1. Emary KRW, Golubchik T, Aley PK, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. The Lancet 397:1351-1362. 10.1016/S0140-6736(21)00628-0. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Affiliations

SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous